ITALIAN NANOMEDICINE PLATFORM (INP) – SUBSCRIPTIONS OPEN
Following the official launch of the Italian Nanomedicine Platform (INP), and in view of the upcoming Kick-off Meeting in Rome (16–18 February 2026), subscriptions to the INP Platform are now open through the dedicated online form.
The first subscription deadline has been extended to February 9th, 2026
SIGNUP LINK
WHY SUBSCRIBE NOW? “FOUNDING MEMBERS” PHASE
This first signup window is designed to build the initial core of the Platform. Colleagues who complete their subscription by February 9th will be recognized as part of the INP founding members group, contributing from the outset to shaping the Working Groups (WGs), priorities, and the initial organization of the Platform.
Important: subscription to the INP Platform is independent from the Kick-off Meeting and is not conditional on participating in the event. You are welcome to subscribe even if you cannot attend the February meeting.
WHAT DOES PLATFORM SUBSCRIPTION ENABLE?
Subscribing to the Platform is essential to:
- join and contribute to the Working Groups (WGs);
- receive updates and official communications on INP activities, opportunities, and outcomes;
- support the activation of the INP digital infrastructure, including a members-only area to share documents, coordinate joint initiatives, and map competences and ongoing activities across the community.
By signing up and providing as much information as possible, you will help build a robust and functional database that will improve coordination, visibility, and collaboration across all WGs—strengthening our collective capacity to develop projects, address regulatory and translational challenges, and engage with national and European initiatives.
A fully inclusive Platform: subscriptions will open again
The INP is committed to being open and inclusive. For this reason, subscriptions will reopen after the Kick-off phase, to ensure the broadest possible participation across academia, research centers, clinical institutions, and industry. The February 9th deadline is therefore intended to support an effective start-up and WG activation, while preserving the possibility for additional colleagues and organizations to join in subsequent rounds.
INP objectives
As highlighted during the launch and in the presentation materials, the INP aims to:
- strengthen synergies among academia, research centers, clinical institutions, and industry;
- promote collaborative projects and translational innovation;
- establish a national network aligned with European nanomedicine initiatives;
- support training, regulatory, and industrial transfer activities through an inclusive and open framework.
We warmly encourage you to subscribe within the first call and help shape the Platform from the beginning.
For questions or suggestions, please contact: